概要

Evolution is inevitable and over a decade there has been magnificent evolution in Human, Machine, Process & regulation to deliver one goal- bring safer and cost-effective drugs to patients. Is PV embarking this journey of evolution to improve patient life by supporting pharmaceutical organizations to be more future ready and breaking boundaries of drug development?

DIA India is thrilled to announce the most awaited Pharmacovigilance Conference in the region - the 9th edition of our Annual Pharmacovigilance Conference Themed Evolving Safety Ecosystem – Pharmacovigilance for tomorrow, to be held on June 2-3, 2022 in an entirely virtual format.

At this 9th Pharmacovigilance Conference DIA brings to you key speakers across the industry sharing insights on the changing PV landscape, expanding the vistas of Drug Safety in the light of Emergency usage of vaccines during pandemic to, ushering in Safe Personalised Medicines through advance Healthcare Science.

Featured

Want to learn more about DIA India 9th Pharmacovigilance Conference: Evolving Safety Ecosystem – Pharmacovigilance for tomorrow? You've come to the right site!

Highlights & Features

Highlights & Features

参加対象

Pharmacovigilance And Drug Safety
Risk Management
Pharmacovigilance Compliance
Regulatory Affairs
Medical Affairs
Late Phase Professionals Conducting PMS, Observational And Non-Interventional Studies
Real World Data And Real World Evidence
Technology Professionals

学習目的

Transactional to Transformational Safety Ecosystem - The Future of Pharmacovigilance
Managing Safety in Clinical setting
RWE / RWD
Learnings in PV Ops during a pandemic - Readiness to the future
Changing scenario for Drug Devices Combination in PV
Promise Vs Deliverables of AI in PV
From Risk Management to focussed Risk minimisation measures
Pragmatic approaches towards Trial related injuries causality assessment
Signal Management: Choice between Qualitative & Quantitative Analysis
Role of AI & Innovations in managing high volume for COVID-19 vaccines and therapeutics
Regulatory Intelligence - MDR regulations changes

プログラム委員会

Moin Don Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),
International Society of Pharmacovigilance (ISoP), India
Krishna Bahadursingh Head of Patient Safety
Bristol Myers Squibb, Japan
Prashant Joshi, RPH General Manager & Global Head Account Delivery, MDPS
Wipro Ltd. And Wipro Life Science (WLS), India
Ritu Jaswal Vice President - Pharmacovigilance Operations
Parexel, India
Saket Singh Kumar, MSC Principal Director Global PV Capability Lead - Operations
Accenture, India
J Vijay Venkatraman, MD, MBA Managing Director and CEO
Oviya Medsafe Pvt Ltd, India
Vijay Bhargav Vice President, Lifecycle Safety
IQVIA, India